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Actin Sliding Velocities Are Influenced By The Chemical Driving Force
Of Actin-myosin Binding
Josh E. Baker, Ryan D. Smith, Steven F. Shannon, Travis J. Stewart,
Olivia N. John.
University Nevada Reno, Reno, NV, USA.
It is widely assumed that muscle shortening velocity, V, is solely limited by ac-
tin-myosin detachment kinetics; however, it was recently shown (Hooft et al.,
2007) that V is influenced by a driving force modulated by actin-myosin attach-
ment kinetics and energetics. To further test this hypothesis, we have developed
a novel in vitro motility and force assay that allows us to correlate changes in
internal driving force with changes in V. We alter the driving force by varying
inorganic phosphate, Pi, and blebbistatin concentrations using an in vitro mo-
tility assay to measure corresponding changes in V. We estimate changes in
driving force by calculating the rate, kbreak, at which actin filaments break dur-
ing this assay. We observe that at 30 mM ATP, both V and kbreak decrease by
approximately 50% (V from 1.5 to 0.88 mm$sec1 and kbreak from 0.04 to
0.02 sec1), demonstrating that actin-myosin driving forces in an in vitro mo-
tility assay decrease with V upon addition of Pi. Similarly upon addition of 50
mM blebbistatin, a small molecule known to decrease actin-myosin mechanics
by inhibiting actin-myosin binding kinetics, both V and kbreak decrease by ap-
proximately 50% (V from 1.5 to 0.62 and kbreak from 0.04 to 0.02 sec
1). These
results support the hypothesis that in an in vitro motility assay internal forces
modulated by actin-myosin binding energetics influence actin sliding veloci-
ties, supporting a new paradigm for the mechanism of muscle shortening.
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The bending flexibility of actin filaments, freely suspended in solution or pro-
pelled by heavy meromyosin (HMM) in the in vitro motility assay, was stud-
ied under different experimental conditions using both phalloidin-stabilized
and phalloidin-free filaments (visualized by N-Hydroxysuccinimide-Rhoda-
mine). For actin filaments propelled by HMM, the persistence length (in-
versely related to the bending flexibility) was obtained from exponential fits
to the cosine correlation function for sliding paths. In solution (in the absence
of HMM) both phalloidin free and phalloidin stabilized filaments exhibited
a nearly rectilinear increase (slope z 0.046 mm/mM) in persistence length
upon increased ionic strength of the observation solution (from 40 to 130
mM). For phalloidin-free and phalloidin-stabilized actin filaments (80 mM
ionic strength), LP in solution was 9.2 5 0.8 mm (mean 5 95 % confidence
interval) and 15.7 5 1.1 mm, respectively (> 80 filaments). For phalloidin
free filaments, the persistence length was similar whether the filaments
were propelled by HMM or freely suspended in solution in the absence of
HMM. In contrast, the persistence length for phalloidin stabilized actin fila-
ments was reduced to the same level as for phalloidin free filaments during
HMM induced sliding. The results accord with the idea that a high flexibility
structural state of the actin filament is a perquisite for actomyosin motility.
However, the results do not support ideas that a low-to-high flexibility transi-
tion of the filament should be an important component of the force-generating
step per se. Finally, our results challenge the general view that phalloidin
stabilized filaments behave as native actin filaments in their interaction with
myosin.
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Skeletal muscle, during periods of exertion, experiences several different fa-
tigue based changes in contraction including reductions in force, velocity,
power output, and energy usage. The physiological bases of fatigue induced
changes in contractility stem from many different factors including changes
in neuronal activity, excitation-contraction coupling, and actomyosin contrac-
tion. The direct changes in the actomyosin contractile complex have previously
been shown to be the result of alterations in the levels of metabolites, oxidative
damage, and an increase in myosin regulatory light chain phosphorylation.
Here, we measured the direct molecular effects of fatigue-like conditions on ac-
tomyosin velocity and force generation using the in vitro motility assay. We
examined how changes in ATP, ADP, Pi, and pH affect the ability of the my-
osin to translocate actin. We show that fatigue-induced increases in metabolites
decrease unloaded shortening velocity, with ADP and pH contributing the mostto the observed changes in velocity. We also examined whether myosin regu-
latory light chain phosphorylation alters the sensitivity of the myosin to fatigue-
like conditions. We show that under fatigue-like conditions, phosphorylation
of the myosin regulatory light chian enhances force production and reduces ac-
tin sliding velocity, similar to the effects of phosphorylation under fatigue-like
conditions observed in both muscle fiber and in vitro motility studies. Further-
more, we found that force production by dephosphorylated myosin is very
sensitive to fatigue-like conditions whereas force production by phosphory-
lated myosin is rather fatigue insensitive. These results suggest that phosphor-
ylation of the myosin regulatory light chain in skeletal muscle may serve as
a protective mechanism against fatigue. Supported by NIH-HL077280,
AHA-0435434T (J.R.M.), AHA-0815704D (to M.J.G.), and NIH-HL071778
(D.S-C.).
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The myosin head transforms chemical energy from ATP hydrolysis into me-
chanical work to generate isometric force or to drive muscle shortening. Dur-
ing the power stroke, small changes in the catalytic ATPase site of the actin-
bound myosin head are coupled to tilting of the light-chain binding domain
relative to the catalytic domain. In this mechanism distortion of an elastic el-
ement within the actomyosin complex is essential for strain to develop prior
to movement.
We have studied missense mutations naturally occurring in Familial Hyper-
trophic Cardiomyopathy (FHC) to test molecular mechanisms and functional
roles of specific domains of the myosin head. Slow soleus muscle fibers (ex-
pressing the ventricular myosin isoform) of FHC-patients were used for these
studies. Previously we found that mutation R723G which is located in the
converter domain of the myosin head increases active force and resistance
to elastic distortion (fiber stiffness) during contraction, relaxation, and rigor,
while cross-bridge cycling kinetics were unchanged. This indicated that the
converter is the part of the actomyosin complex where most of the elastic
distortion occurs.
We now included mutation R453C located near the nucleotide binding pocket
of myosin in our functional studies. This mutation was found to also increase
active force, however, without affecting fiber stiffness. Instead, mutation
R453C increased fiber ATPase activity and the rate constant of force redevel-
opment (kredev) significantly, which were unchanged by mutation R723G.
Thus, both FHC mutations cause force enhancement in muscle fibers from
FHC patients, however, by distinctly different mechanisms. R723G affects re-
sistance to elastic distortion of the myosin head while R453C alters cross-
bridge cycling kinetics. The data underline the different functional roles of
the domains within the myosin head and point to an involvement of residue
R453 in human ventricular myosin ATPase activity.
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We investigated the kinetic properties of two homozygous-viable Drosophila
myosin mutants, D45 (A261T) and Mhc5 (G200D). The D45 mutation is located
near b7, while the Mhc5 mutation is located at the N-terminal side of loop 1.
D45 was originally identified as a suppressor of the troponin I (TnI) hdp2 mu-
tation, which causes muscle hypercontraction, resulting in a wings-up pheno-
type. The Mhc5 mutation is lethal when co-expressed with hdp2, presumably
enhancing the hypercontraction phenotype. Drosophila hearts, carrying either
the D45 or Mhc5 mutation, demonstrated depressed or enhanced motor func-
tion and this evoked a dilatory or restrictive response, similar to that seen
with vertebrate dilated or restricted cardiomyopathy myosin mutations. Using
flash photolysis, our transient kinetics results suggest that suppression of the
TnI hypercontraction phenotype is accomplished by expression of a less-active
myosin (D45), whereas enhancement of muscle hypercontraction can be
achieved with the expression of an overactive myosin isoform (Mhc5). Both
